EURAMED The Medical platform for Radiation Protection Research

Slides:



Advertisements
Similar presentations
1 Nuclear Fission and Radiation Protection In FP6 Towards a new way of working Hans Forsström European Commission DG Research Directorate J, Unit 4: Nuclear.
Advertisements

4/2003 Rev 2 I.1.1 – slide 1 of 13 Session I.1.1 Part I Review of Fundamentals Module 1Introduction Session 1Learning Objectives, Course Table of Contents.
International Federation of Accountants International Education Standards for Professional Accountants Mark Allison, Executive Director Institute of Chartered.
Establishment of a Training Dosimetry Laboratory in Cairo University Dr. Hassan Fathy for NSPA.
SAFA- IFAC Regional SMP Forum
Supported by the European Commission, contract number: Fission , and the Research.
SÄTEILYTURVAKESKUS STRÅLSÄKERHETSCENTRALEN RADIATION AND NUCLEAR SAFETY AUTHORITY Protection of the environment from ionising radiation - views of a regulator.
PART IX: EMERGENCY EXPOSURE SITUATIONS Module IX.1: Generic requirements for emergency exposure situations Lesson IX.1-2: General Requirements Lecture.
Supported by the European Commission, contract number: Fission , and the Research.
Protection Against Occupational Exposure
EURATOM RESEARCH AND TRAINING ON NUCLEAR ENERGY 1.
Belgian dosimetric database : prospect and practical aspects Information session on aircrew exposure to cosmic radiation Brussels, January 20 th 2009 A.
Patient safety panel Magdalena Machalska EPF Policy Assistant.
Crosswalk of Public Health Accreditation and the Public Health Code of Ethics Highlighted items relate to the Water Supply case studied discussed in the.
1 HERCA: Heads of the European Radiological protection Competent Authorities – Working Group Medical Applications Clinical Radiology Audit Forum
Future goals of EFOMP in education, profession and science.
INTERNATIONAL COMMISSION ON RADIOLOGICAL PROTECTION —————————————————————————————————— Optimisation of Radiological Protection in ICRP’s New Recommendations.
56th Regular Session of the IAEA General Conference
IAEA International Atomic Energy Agency Regulations Part III: Radiation Protection Performance Requirements Day 8 – Lecture 5(3)
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
IAEA International Atomic Energy Agency. IAEA 2 Reality and Perspectives of Timor Leste in the context of the Bonn Call for Action Dr. Abraham Gregorio.
Some reasons for unnecessary procedures
Energy Georgi Simeonov European Commission DG ENER, Radiation Protection Unit (D3) Justificação e Optimização das Exposições Médicas a Radiações Ionizantes.
Diagnostic reference levels in Medical Imaging. Concept and practice
Radiation Sources in medicine diagnostic Radiology
International Atomic Energy Agency Medical exposure in radiology: Scope and responsibilities Module VIII.1 - Part 2 : Training.
EU Basic Safety Directive 2013/59/Euratom TRAINING COURSE ON TECHNICAAL REQUIREMENTS TO FULFILL NATIONAL OBLIGATIONS FOR THE SAFE MANAGEMENT OF DSRS.
RER/9/111: Establishing a Sustainable National Regulatory Infrastructure for Nuclear and Radiation Safety TCEU School of Drafting Regulations November.
Radiation Safety Regulations
Policy statement issued by the Network of European NGO’s dedicated to injury prevention Working together to make Europe a safer place Wim Rogmans secretary.
OPTIMISATION OF RADIATION PROTECTION (ALARA): A PRACTICAL GUIDEBOOK Sotirios ECONOMIDES (GAEC, Greece), Cristina NUCCETELLI (ISS, Italy), Serena RISICA.
Energy Georgi Simeonov European Commission DG ENER, Radiation Protection Unit 15th European ALARA Network Workshop and 5th EUTERP Workshop Education and.
15th European ALARA Network Workshop and 5th EUTERP Workshop Annemarie Schmitt-Hannig Recent Developments within the European Framework of RP Education.
IAEA International Atomic Energy Agency IAEA Safety Standards and Public Exposure to Radon Trevor Boal Radiation Protection Unit - NSRW.
Meet your Regulator Workshop with FANR licensees October 2011 Dr. John Loy Director, Radiation Safety Federal Authority for Nuclear Regulation.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
The European Transport Research Alliance - ETRA Prof. G. A. Giannopoulos Chairman, ETRA.
Organization and Implementation of a National Regulatory Program for the Control of Radiation Sources Need for a Regulatory program.
BY GAMINI SENANAYAKE.  Legislation applicable to staff and public Ionising radiation regulations 1999  Legislation applicable to patients – Ionising.
Impact and the Physical Sciences
TRAINING AND CULTURAL PROBLEMS TO BE SOLVED IN THE MEDICAL AREA FOR IMPROVING THE IMPLEMENTATION OF THE ALARA PRINCIPLE I-L Lamm EFOMP History.
 Progress with the revision and consolidation of the European Basic Safety Standards Directive Stefan Mundigl, Vesa Tanner European Commission DG Energy.
Christian Lefuare John Croft CEPN NRPB
Observations and Lessons from OECD/NEA Activities in Stakeholder Involvement Summary of Experience from the NEA Committee on Radiation Protection and.
Strategies to Reduce Antibiotic Resistance and to Improve Infection Control Robin Oliver, M.D., CPE.
The Success of the ALARA Principle – the View of an Inspector
E.U. Public Policy Professor John Wilton Lecture 10 Environment policy
Vesa Tanner European Commission Directorate-General Energy
AAEA Role in Improving EPR Coordination Interventions among Arab Countries Abdelmajid Mahjoub Arab Atomic Energy Agency
Pediatric Radiology By Dr. Wambani, J.S. Chief Radiologist
This is an archived document.
Radiation Dose Management (RDM) Market to Cross $1.7 billion by 2023.
The pathological effects of ionising radiation
Helen Lee, European Commission
EU Reference Centres for Animal Welfare
Principles of Radiation Protection
Leadership and Management for Safety
The role of the ECCP (1) The involvement of all relevant stakeholders – public authorities, economic and social partners and civil society bodies – at.
Access to HIV/AIDS Medicines The 3x5 strategy
WHAT IS RISS? The Rural innovation Support Service (RISS) is a bottom-up approach to rural innovation, addressing the needs of land managers RISS gets.
ICRP Views on Radiation Risk at Low Doses through the Lens of Fukushima Applicability of Radiation-Response Models to Low Dose Protection Standards Tri-Cities,
National Cancer Center
Patient Safety WalkRounds
Update on “Team working in Clinical Imaging ” 11th October 2018
Setting conservation objectives for Natura 2000
Philippe QUEVAUVILLER
League of Advanced European Neutron Sources
Optimisation in Operational Radiological Protection
Realistic Prescribing Pathways
RCA Workshop on RCARO Future Strategies July 2007
Presentation transcript:

EURAMED The Medical platform for Radiation Protection Research Graciano Paulo IPC-ESTESC Coimbra Health School Ciência 2017 (Lisbon 5th July)

The European Alliance for Medical Radiation Protection Research (EURAMED) represents a consortium of associations involved in the application of ionising radiation in medicine, namely: the European Association of Nuclear Medicine (EANM), the European Federation of Organisations for Medical Physics (EFOMP), the European Federation of Radiographer Societies (EFRS), the European Society of Radiology (ESR), the European Society for Radiotherapy and Oncology (ESTRO), with the goal of jointly improving medical care and its radiation protection issues through sustainable research efforts.

The other platforms are namely: Context EURAMED complements existing established European platforms in several other fields of radiation protection and will thus create visibility for the medical field in this context. The other platforms are namely: Multidisciplinary European Low Dose Initiative (MELODI) European Radiation Dosimetry Group (EURADOS) European Platform for nuclear and radiological emergency response and recovery (NERIS) European Radioecology Alliance (ALLIANCE)

Vision To lead the European research activities in medical RP and to assume an umbrella function for the harmonisation of practice to advance the European RP safety culture in medicine Mission To jointly improve medical care through sustainable research efforts in medical radiation protection Identification of common research areas defined in a common strategic research agenda To serve as a platform for medical radiation protection research, linking researchers and clinicians, adopting a harmonised approach to lobbying at European level to impact the European research funding landscape To develop an aligned approach and response to European research calls

EURAMED Working Group Members: Christoph Hoeschen, Uni Magdeburg/DE, Chair John Damilakis, EFOMP Wolfgang Doerr, ESTRO Guy Frija, ESR Gerhard Glatting, EANM Hans Langendijk, ESTRO Kristoff Muylle, EANM Graciano Paulo, EFRS Wolfram Stiller, ESR Virginia Tsapaki, EFOMP Jonathan McNulty, EFRS Monika Hierath, EIBIR (Support)

Purpose of the Society The Society shall be an apolitical, non-profit organisation, exclusively and directly dedicated to promoting and coordinating the scientific, philanthropic, intellectual and professional activities in the field of medical radiation protection research. The Society’s mission at all times is to serve the health care needs of the general public through the support of science and research and the quality of service in medical imaging and therapy involving ionising radiation.

The research that is seen to be necessary and most urgent for effective medical care, under the best harmonised practice, and efficient in terms of radiation protection can be summarised to the following five main topics: Measurement and quantification in the field of medical applications of ionising radiation Normal tissue reactions, radiation-induced morbidity and long-term health problems Optimisation of radiation exposure and harmonisation of practices Justification of the use of ionising radiation in medical practice Infrastructures for quality assurance

Measurement and quantification in the field of medical applications of ionising radiation A key priority for radiation protection research in radiation oncology, nuclear medicine and also interventional and diagnostic applications of ionising radiation is to improve techniques and methods for measurement and quantification.

Normal tissue reactions, radiation-induced morbidity and long-term health problems A key priority for radiation protection research in radiation oncology, nuclear medicine and also interventional and diagnostic applications of ionising radiation is is to improve health risk estimates.

Optimisation of radiation exposure and harmonisation of practices According to the European Basic Safety Standard (BSS) (2013/59/EURATOM), the radiation protection of individuals subject to public or occupational exposure must be optimised with the aim of keeping the magnitude of individual doses, the likelihood of exposure and the number of individuals exposed as low as reasonably achievable (ALARA) taking into account the current state of technical knowledge, economic and societal factors. The optimisation of the protection of individuals subject to medical exposure should be consistent with the medical purpose of the exposure.

Justification of the use of ionising radiation in medical practice The principle of justification is one of the key pillars of radiation protection underlined in the recently revised European BSS Directive. This principle focusses on weighing the benefits versus the risks. Further important elements are patient communication, as the basis for shared decision-making including the patient rights for influencing the decision, as well as the appropriateness of the radiological procedure with respect to the clinical setting.

Infrastructures for quality assurance To perform investigations on tissue reactions, optimisation procedures as well as risk and benefit evaluations, it is important to rely on optimal, quality assured data, which are gathered under defined conditions and which are necessary for various reasons including legal questions pertaining or specific to the research to be performed. In addition, the clinical system of medical applications of ionising radiation has to be standardised and evaluated concerning its effectiveness in radiation protection.

EURAMED Final Message It is essential that any research in the area of medical ionising radiation is translated into clinical practice to ensure that patients and staff see the direct benefits of this research. There is evidence that this translational research often fails because of the absence of parallel education and training programmes. High quality education and training programmes will raise awareness of ongoing EU research projects and initiatives and ensure their uptake into clinical practice at local, national and European levels. There has been an identified need to also develop high-quality education and training specifically for researchers to help strengthen the medical ionising radiation research community.

EURAMED The Medical platform for Radiation Protection Research Graciano Paulo IPC-ESTESC Coimbra Health School graciano@estescoimbra.pt Ciência 2017 (Lisbon 5th July)